ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,951, issued on May 13, was assigned to The Beckley Foundation (Oxford, Great Britain).
"Compounds for use in a method of treating or preventing neurological and/or psychiatric disorders" was invented by Sidarta Ribeiro (Natal-NR, Brazil) and Amanda Feilding (Oxford, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds, i.e. ergoline derivatives, such as lysergic acid diethylamide, or pharmaceutically acceptable salts thereof for use in a method of treating (alleviating), preventing, reducing the symptoms of and/or slowing down the progression of a neurological and/or psychiatric disorder, such as mi...